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Abstract: While the detrimental effects of a chronic positive energy balance due to a sedentary lifestyle
have been well established, the impacts of a short period of abruptly reduced physical activity and
overeating arising from strict confinement due to the COVID-19 pandemic will soon start to emerge.
To reasonably anticipate major consequences according to the available evidence, we hereby review
the literature for studies that have explored the health impacts of several weeks of a reduction in
physical activity and daily step-count combined with modified eating habits. These studies identify
as main metabolic consequences increases in insulin resistance, total body fat, abdominal fat and
inflammatory cytokines. All these factors have been strongly associated with the development of
metabolic syndrome, which in turn increases the risk of multiple chronic diseases. A plausible
mechanism involved in these impacts could be a positive energy balance promoted by maintaining
usual dietary intake while reducing energy expenditure. This means that just as calorie intake
restriction could help mitigate the deleterious impacts of a bout of physical inactivity, overeating
under conditions of home confinement is very likely to exacerbate these consequences. Moreover,
hypertension, diabetes, and cardiovascular disease have been identified as potential risk factors for
more severely ill patients with COVID-19. Thus, adequate control of metabolic disorders could be
important to reduce the risk of severe COVID-19.
Keywords: COVID-19; acute sedentary lifestyle; step reduction; positive energy balance; metabolic
consequences; insulin resistance; metabolic syndrome; sarcopenia
1. Introduction
The current COVID-19 pandemic has led governments of the mainly affected countries to impose
strict confinement rules on their citizens. These include measures such as working from home and
closing schools, shops, restaurants and any business or service considered non-essential in order
to slow down the spread of the contagion and thereby prevent the collapse of health care systems.
These measures have, however, had their impacts on the general health of the population because of
both exercise restrictions and effects on diet. Exercise restrictions have been the consequence of closed
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gyms and sports centers, restrictions on walking distance, lack of space and infrastructure of homes for
physical exercise, and lack of technical knowledge of the population on appropriate training routines.
Effects on nutrition include limited access to shops, a poorer quality of food products due to the
already visible impacts on family income, and overeating. Before this pandemic, insufficient physical
inactivity was already described as a global public health problem, with over a quarter of all adults
not undertaking the levels of physical activity required for good health [1]. As a result of the current
situation in which many people are confined to their homes, physical activity and exercise levels
drastically decline while dietary habits remain unchanged or fail to offset this inactivity producing a
positive energy balance. There is strong epidemiological evidence that a chronic sedentary lifestyle is
detrimental for health [2,3]. Likewise, there is evidence that such negative effects persist even when
performing physical exercise programs, revealing that it is just as important to reduce sitting times as
it is to lengthen exercising periods [4].
Exercise plays a fundamental role in the prevention of most chronic diseases. Our body needs a
relatively long period to benefit from the healthy adaptations that exercise generates, modulated by
different molecular mechanisms such as epigenetics, metabolic modulation or reduced inflammation [5–13].
Unfortunately, it requires only a period of a few days to reverse these adaptations, and the body returns
to a physiological situation similar to baseline or even worse [2]. This means that trying to maintain an
active lifestyle during home quarantine is essential to avoid physical consequences and this approach
may also help mitigate the psychological impacts of confinement, especially among the elderly [14–16].
To analyze the consequences of physical inactivity and an acute positive energy balance due to
changes in eating habits, different models have been employed [17,18]. Nevertheless, these interventions
do not reflect the current home confinement situation, in which daily physical activity is drastically
reduced and there is a tendency to eat more and worse affecting the risk of metabolic-associated chronic
diseases such as cardiovascular diseases (CVD) across a large part of the world population (Figure 1).
This paper therefore reviews evidence of the metabolic-health impacts of a short period of a reduction
in physical activity and a tendency to overeat.
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2. Methods
Electronic databases (Medline, EMBASE, and Web of Science) were searched without language
restrictions to ide tify all reports on metabolic-r lated alteratio s, physic l inactivity an overfeeding.
Inclusion criteria were: (i) publication in a peer-reviewed journal, (ii) human study, (iii) studies
examining the impacts of acute physical inactivity, and (iv) studies examining the impacts of acute
changes in dietary habits. Reasons for exclusion were: (i) studies in non-adult subjects, (ii) no control
group, (iii) data reported not usable.
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3. Results and Discussion
3.1. Metabolic Consequences of Acute Physical Inactivity in Healthy Adults
In this section, we review the impact of acute physical inactivity on glycemic control, inflammatory
markers, body composition and cardiorespiratory fitness (CRF) in healthy young adults (Table 1).
Pedersen et al. [19,20] employed a step reduction model to examine the consequences of current
lifestyles involving prolonged periods of inactivity interspersed with short episodes of low to moderate
physical activity. In their investigation, participants were instructed to reduce daily steps by taking
lifts instead of stairs and using their cars instead of walking or cycling.
The two following studies were conducted on healthy young men who performed less than 2 h
of regular exercise per week and walked more than 3500 steps per day. During the interventions,
participants maintained their usual dietary habits. In the first study, participants were recruited for
2 sub-studies [19]. In the first sub-study [19], eight participants (27.1 (5.7) years; body mass index (BMI)
22.9 (4.0) kg/m2) reduced their activity from 6203 steps/day (5135–7271) to 1394 steps/day (1261–1528)
for three weeks. Results included a significant increase in the area under the curve (AUC) for plasma
insulin during an oral glucose tolerance test (OGTT) from baseline to the third week. In the second
sub-study of the first study [19], ten subjects (23.8 (4.6) years; BMI 22.1 (2.1) kg/m2) reduced their
mean activity level of 10,501 steps/day (8755–12,247) to 1344 steps/day (1272–1416) for 2 weeks. In this
study, both plasma insulin AUC and plasma C-peptide levels increased significantly after the inactivity
period. In the oral fat tolerance test, AUCs for plasma insulin, C-peptide and triglycerides (TG) also
increased significantly. Further, while total fat mass (FM) remained unchanged, intra-abdominal FM
increased (by 7%) after the two weeks of step reduction, and this was accompanied by a significant
reduction in total free fat mass. In the second study [20], ten young healthy males (23.8 (1.5) years; BMI
22.1 (0.7) kg/m2) reduced their daily steps from a baseline value of 10,501 (808) to 1344 (33) for two
weeks. This step reduction led to a decreased glucose infusion rate due to a reduction in peripheral
insulin sensitivity, and a concurrent decrease in insulin-provoked muscle Akt phosphorylation with no
effect on endogenous glucose production in the liver. In contrast to the results of study 2 [19], there was
no significant change in total FM after step reduction, but leg lean mass was lower. Finally, two weeks
of physical inactivity did not produce changes in plasma levels of TG, free fatty acids (FFA), glucose,
insulin or C-peptide.
Interestingly, the findings of a similar study indicated that just three days of step reduction from
12,956 (769) to 4319 (256) steps/day led to impaired glycemic control in twelve healthy active participants
(8 men, 4 women; 29 (1) years; 23.6 (0.9) kg/m2) [21]. In response to this short intervention, the authors
also noted increased postprandial glucose levels, increased fasting plasma insulin and C-peptide
responses to OGTT, along with increased insulin resistance and diminished insulin sensitivity.
Maximal aerobic capacity (VO2max) is a major predictor of functional capacity and is the gold
standard indicator of CRF. A person’s VO2max also reflects pulmonary and muscle function, nutritional
status or the health state of other organ systems. While higher CRF is associated with better health,
lower CRF is associated with increased mortality independently of other risk factors [2]. Several
studies [20,22–24] have determined the effects of an acute period of inactivity on VO2max. Results
indicated that following two weeks of physical inactivity VO2max was reduced when participants
maintained their normal diet [20,24], when calorie intake was restricted [23] or when intake was
increased by 50% kcal [22]. In two of these studies, nevertheless, it was found that VO2max returned to
baseline after normal physical activity was resumed [22,24].
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Table 1. Summary of the studies reviewed examining the effects of acute physical inactivity and/or overfeeding.
Study Subjects Intervention Blood Parameters InflammatoryParameters Lipid Profile Body Composition CRF
Olsen et al. 2014 [19]
8 healthy men
<2 h EX/week, >3500 steps/day
27.1 (5.7) years
BMI 22.9 (4.0) kg/m2
3-weeks SR
6203 (5135–7271) to 1394 (1261–1528) steps/day
Maintained dietary habits
OGTT
↑ insulin AUC Not reported Not reported Not reported Not reported
10 healthy men
<2 h EX/week, >3500 steps/day
23.8 (4.6) years
BMI 22.1 (2.1) kg/m2
2-week SR
10,501 (8755–12,247) to 1344 (1272–1416) steps/day
Maintained dietary habits
OGTT
↑ insulin AUC, C-peptide levels
OFTT
↑ insulin, C-peptide, TG
Not reported Not reported
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26 healthy men 
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1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
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Krogh-Madsen et al. 2010
[20]
10 healthy men
<2 h EX/week, >3500 steps/day
23.8 (1.5) years
BMI 22.1 (0.7) kg/m2
2-week SR
10,501 (808) to 1344 (33)
Maintained dietary habits
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↓ peripheral insulin sensitivity (H-E)
↓ insulin provoked muscle Akt phosphorylation
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↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not traini g 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
TG, FFA
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
dec ased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (29 ) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ lasma glucose, C-peptide, hepatic 
glucose pr duction 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day r sumed us al PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn t al. 
2019 [23] 
 
10 h althy participants 
(4 F, 6 M)  
>90 min PA 3 
ays/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2 h insulin, C-pept de, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et l. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AU  
 , , I - , 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
 
 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adipo ectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
FM
↓ BM, leg lean mass
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
s p /day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insuli  sen itivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucos  production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
trunk and arm lean mass
↓ VO2max
Mikus et al. 2012 [21]
12 healthy participants (4 F, 8 M)
>10000 steps/day
29 (1) years
BMI 23.6 (0.9) kg/m2
3-day SR
12,956 (769) to 4319 (256) steps/day
Maintained dietary habits
CGM
↑ post-prandial glucose, fasti g insulin
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, w ist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
pre- eal blood glucose, 24 h average glucose
OGTT
↑ insulin AUC, C-peptide, HOMA-IR
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 ) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and re uming of PA  
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass
FDR+ve: >incre se 
of ndroid fat 
↓ VO2max 
2-week resu ed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal t  4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral nsulin sensitivity (H-E)
↔ plasma glucose, C-peptide, hep tic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, androi  
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to ba eline Remained elevated 
Returned 
t  baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extracti n, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
glucose AUC
↓Matsuda
Not reported Not rep r ed Not repor ed Not rep rt d
Dixon et al. 2013 [25]
18 healthy men
EX > 30 min/ 5 d/week
9 overweight: 49 (1.0) years
BMI 29.3 (1.2) kg/m2
9 lean men: 51.5 (1.4) years
BMI 29.3 (1.2) kg/m2
1-week SR
<4000 steps/day
Maintained dietary habits
OGTT
↑ in ulin AUC, glucose AUC
Ov rweight: >insulin AUC, glucose AUC
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Bowden-
Davies et al. 
2018 [24] 
45 healthy p rticipants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintain d di tary h bits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ M tsuda, m scle insulin sensitivity 
↔ hepatic i sulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-wee  resume  usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resume  usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-p ptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
CRP, IL-6, TNF-α,
WBC, sICAM, ALT
Overweigh: >CRP, ALT
↑ TG
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Bowden-
Davies et al. 
2018 [24] 
45 healthy p rticipants 
(28 F, 17 M) >10,00  
, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285)
Maintained dietary habits 
OGTT 
↑ insulin AUC, gluco  AUC 
↓ Matsud , uscle insulin s nsitivity 
↔ hepatic ins lin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not report d ↑ TC, LDL- , TG 
↑ M. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resume  usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
st ps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(d y 3, day 7) 
↔ glucose AUC 
↓ Peripheral insul  s nsitivity (H-E) 
↔ plasm  glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, G 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (4 0 
kcal/day deficit)  
4-week washou  
10-day SR + higher prote  diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, i sulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and i sulin 
Not reported 
↔ TG, LDL-c, 
ox dized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfee ing (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
FFA, TC, HDL-c,
LDL-c
Overweight: >FFA, TG
Not reported Not reported
Bowden-Davies et al.
2018 [24]
45 healthy participants (28 F, 17 M) >10,000
steps/day, >2 h EX/week
16 FDR+ve: 40(14) yearsBMI 27 (5) kg/m2
29 FDR-ve: 33 (13) years
BMI 24 (3) kg/m2
2-week SR
<1500 steps/da (mean decreased: 10,285)
Maintained dietary habits
OGTT
↑ insulin AUC, glucose AUC
↓Matsuda, muscle insulin sensitivity
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivi y 
↔ hepatic insulin resi tance, NEFA 
AUC 
FDR+ve: <ins lin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean ass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin s nsitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production
↔ TNF-α, IL-6 
↑ l ptin, 
adiponectin 
↔ FFA, TG 
↑ BM, , android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Return d 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (88  
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucos , 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
hepatic insulin resistance, NEFA AUC
FDR+ve: <insulin sensitivity (after SR and resuming of PA)
Not reported ↑ TC, LDL-c, TG
↑ FM. liv r at
↓ total l an mass, lower limb lean mass
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OGTT 
↑ insulin AUC, glucose AUC 
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a d resuming of PA) 
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2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
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↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
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↑ BM, FM, droid 
and visceral fat 
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↓ VO2max 
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Winn et al. 
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10 healthy participants 
(4 F, 6 M)  
>90 min PA 3
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
gl cose a d insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
arm lean ass
FDR+ve: >increase of android fat
↓ VO2max
2-week resumed usual PA
Knudsen et al. 2012 [22]
9 healthy men
>10,000 steps/day
24.3 (3.3) years
BMI 21.6 (2.5) kg/m2
2-week SR + overfeeding
10,278 (2399) to 1521 (488) steps/day
2762 (299) kcal to 4197 (290) kcal
OGTT
↑ insulin AUC (day 7, day 14), Matsuda (day 3, day 7)
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BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kc l 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, F , android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, RP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
glucose AUC
↓ Peripheral insulin sensitivity (H-E)
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steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
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10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protei  diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose an  insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
plas a glucose, C-peptide, hepatic glucose production
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↔ hepatic insulin resistance, NEFA 
AUC 
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a d resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm le n mass
FDR+ve: >i crease 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
TNF-α, IL-6
↑ leptin, adiponectin
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9 healthy men 
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glucose production 
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and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usu l PA Returned to baseline Remained elevated 
Returned 
to baseline 
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 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
k al/d y defic t)  
4-week washout 
10-day SR + higher protein d et 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HD -C, TC 
↓ BM abdominal 
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↔ FFM, FM 
↓ VO2max 
10-day SR + overf eding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
FFA, TG
↑ BM, FM, android and visceral fat
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10-day SR (>10,000 to <50,000 
step/day) + contro  diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + ov rfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + ov rfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
FFM
↓ VO2max
16-day re umed usual PA Returned to baseline Remained elevated Returned to baseline
Winn et al. 2019 [23]
10 healthy participants (4 F, 6 M)
>90 min PA 3 days/week and >10,000
steps/day
24 (1) years
BMI < 28 kg/m2
10-day SR (>10,000 to <50,000 step/day) + control diet
(400 kcal/day deficit)
4-week washout
10-day SR + higher protei diet (400 kcal/day fi it)
OGTT
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Bowden-
Davies et al. 
2018 [24] 
45 healt y participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285  
Maintained etary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistan , NEFA 
AUC 
FDR+ve: <i s li  sensitivity after SR
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean
mas  
↔ ar  lea  mass 
FDR+ve: >incre se 
of android fat
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ ep i , 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral f t 
↔ FFM 
↓ VO2max 
16-day resum d usual PA Returned to baseline Remained elevated 
Returned 
to baseli e 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HD -C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not r ported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
T 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
report d 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
Postpr ndial glucose, insuli , NEFA, 2-h glucose and 2-h insulin,
C-peptide, hepatic insul n extraction, plasma glucose and insulin
Not reported
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/w ek 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-we k SR  
<1500 steps/d y ( ean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insuli  AUC, glucose AUC 
↓ Mats da, mus le insulin sensitivity 
↔ e atic i s li  resistance, NEFA 
AUC
FDR+ve: <insulin se sitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, L -c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+v : >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10, 00 teps/day 
24.3 (3.3) ye rs 
BMI 2 .6 2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-pepti e, hepatic 
glucose pro uctio  
 TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit)
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
 glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day tread ill u ning at
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ LT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
TG, LDL-c, oxidized
LDL
↓ HDL-C, TC
↓ BM bdominal FM
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Bowde -
Davies et al.
2018 [24] 
45 h lth participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/ 2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-we k SR  
<1500 steps/day (mean 
d creased: 10,285)
Ma tai ed dietary habits 
OGTT 
↑ insulin AU , glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 20 2 [22]
9 healthy m n 
>10,000 steps/d y 
24.  (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) o 1521 (488) 
step /day 
2762 (299) cal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Ma suda 
(day 3, day 7) 
↔ gluc se AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
 TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 health  partici nts 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
gl cos  a d insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-we k SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
 ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
FFM, FM
↓ VO2max
10-day SR + overfeeding (880 kcal/d)
OGTT
↑ HOMA-IR, 2h-gluc se, 2h- sulin
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10, 00 
steps/day, >2 h 
EX/week
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsud , muscle in lin sensitivity 
↔ he atic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LD -c, TG 
↑ FM. liver f t 
↓ total lean mass,
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 15 1 (488) 
steps/d y
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insul  AUC (day 7, day 14), Mat uda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sens tivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponec in 
↔ F A, TG 
↑ BM, FM, ndroid 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returne  to baseline Remained elevated 
eturned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 i  PA 3 
days/week and >10,000 
steps/day 
24 (1) years
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxi iz d LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
glucose UC, NEFA
↑ plasma gluco e, ins lin, C-peptide
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<150  steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle i ulin s nsitivity 
↔ hepa ic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean ass, 
lower limb lean 
mass 
↔ rm lean mass 
FDR+v : >i crease 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 health  men 
>10,000 steps/day 
24.3 (3.3) y ars 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Periph r l insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and -h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
 glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
hepatic insulin extraction
Not rep rted
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Bowde -
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGT  
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insuli  sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and r suming of PA) 
Not reporte  ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [ 2] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3,  7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
 plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control iet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, i suli , NEFA, 
2-h glucose and 2-h insulin, -peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
 TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
TG, T , HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FF  ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
 HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
TG, TC, HDL-c, LDL-c,
oxidized LDL
↑ BM, F
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Bowden-
Davies et al. 
2018 [24] 
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Table 1. Cont.
Study Subjects Intervention Blood Parameters InflammatoryParameters Lipid Profile Body Composition CRF
Walhin et al. 2013 [26]
26 healthy men
Vigorous-intensity EX > 30 min/ 3 day/week
25 (7) years
BMI 23.8 (2.5)
1-week SR: 12,562 (3520) to 3762 (860) + overfeeding
(+50% kcal) + 45 min/day treadmill running at 70%
VO2max
OGTT
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Matsuda, B- cell function, insulin AUC
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26 healthy men 
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ALT, CRP, IL-6, WBC
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26 healthy men 
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BMI 23.8 (2.5) 
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↑ BM, waist/hip circumference, lean mass
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kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucos  AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 h lthy men 
Vigorous-intensity EX 
> 30 mi / 3 day/week 
25 (7) years 
BMI 23.8 2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+ 0% kcal) + 
45 min/day tr admill runni g at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, i sulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ A T, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
HDL-C. LDL-C,
NEFAs, TG
↑ BM, waist/hip circumference, lean mass
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-w ek SR  
<1500 steps/day (mean 
decreased: 10,285) 
Mai tained die a y habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Periph ral insuli  sen itivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day d ficit) 
4-week w hout 
10-day SR + higher protein iet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plas a glucose, insulin, C-peptide 
hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell functi n  
↑ insulin AUC OG T 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
FM
Not reported
Breen et al. 2013 [27]
10 healthy older adults (5 F, 5 M)
>3500 steps/day
72.3 (1.0) years;
BMI 29.0 (1.8) kg/m2
2-week SR: 5962 (695) to 1413 (110) steps/day
Maintained dietary habits
OGTT
↑ HOMA-IR, glucose AUC and AUC
↓Mat da
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin r sistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned t  baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M) 
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
C-peptide AUC
↑ TNF-α, CRP
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000
steps/day, >2 h
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m  
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maint ined dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
 arm lean mass 
DR+v : >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h nsulin, C-peptide, 
hepat  insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucos , insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
 FFM 
↓ VO2max 
Walh  et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
Matsuda, B- cell fun tion, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
IL-6
Not reported
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285) 
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean ass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AU  
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [ 3] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
step/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-i sulin 
↔ glucose AUC, NEFA 
↑ plasma glucos , i sulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, H L-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-w ek SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ F  
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ T 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
total FM, FM
↓ leg FFM
↑% FM
↓MPS
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
years 
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day ( ean 
decreas d: 10,285) 
Maint ined dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity (after SR 
and resuming of PA) 
Not reported ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass 
FDR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
K udsen et 
al. 2012 [22] 
9 healthy men 
>10,000 steps/day 
24.3 (3.3) years 
BMI 21.6 (2.5) kg/m2
2-week SR + overf ding 
10,278 (2399) to 15 1 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
gluc se produ tion 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Retur ed to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA 3 
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
ste / ay) + control diet (400 
kcal/day defi it)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kcal/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
↔ glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
isometric MVC, SPPB
Not reported
McGlory et al. 2018 [28]
22 healthy older adults >3500 steps/day
12 M: 69 (3) years; BMI 27.3 (4.6)
10 F: 70 (5]) years; BMI 27.7 (5.1)
2-week SR: 7362 (3294) to 991 (97) steps/day
Maintained dietary habits
2-week resumed usual PA
OGTT
↑ glucose and insulin AUC, HOMA-IR
↓Matsuda
↑ TNF-α, CRP, IL-6 Not reported
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Bowden-
Davies et al. 
2018 [24] 
45 healthy participants 
(28 F, 17 M) >10,000 
steps/day, >2 h 
EX/week 
16 FDR+ve: 40(14) 
ears
BMI 27 (5) kg/m2 
29 FDR-ve: 33 (13) 
years 
BMI 24 (3) kg/m2 
2-week SR  
<1500 steps/day (mean 
decreased: 10,285  
Maintained dietary habits 
OGTT 
↑ insulin AUC, glucose AUC 
↓ Matsuda, muscle insulin sensitivity 
↔ hepatic insulin resistance, NEFA 
AUC 
FDR+ve: <insulin sensitivity ( fter SR 
and resu ing of PA) 
Not rep rted ↑ TC, LDL-c, TG 
↑ FM. liver fat 
↓ total lean mass, 
lower limb lean 
mass 
↔ arm lean mass
DR+ve: >increase 
of android fat 
↓ VO2max 
2-week resumed usual PA 
 
Knudsen et 
al. 2012 [22] 
9 h althy men 
>10,000 steps/day 
24.3 (3.3) year  
BMI 21.6 (2.5) kg/m2 
2-week SR + overfeeding 
10,278 (2399) to 1521 (488) 
steps/day 
2762 (299) kcal to 4197 (290) kcal 
OGTT 
↑ insulin AUC (day 7, day 14), Matsuda 
(day 3, day 7) 
↔ glucose AUC 
↓ Peripheral insulin sensitivity (H-E) 
↔ plasma glucose, C-peptide, hepatic 
glucose production 
↔ TNF-α, IL-6 
↑ leptin, 
adiponectin 
↔ FFA, TG 
↑ BM, FM, android 
and visceral fat 
↔ FFM 
↓ VO2max 
16-day resumed usual PA Returned to baseline Remained elevated 
Returned 
to baseline 
Winn et al. 
2019 [23] 
 
10 healthy participants 
(4 F, 6 M)  
>90 min PA  
days/week and >10,000 
steps/day 
24 (1) years 
BMI < 28 kg/m2 
10-day SR (>10,000 to <50,000 
st p/day) + control diet (400 
kcal/day deficit)  
4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
2-h glucose and 2-h insulin, C-peptide, 
hepatic insulin extraction, plasma 
glucose and insulin 
Not reported 
↔ TG, LDL-c, 
oxidized LDL 
↓ HDL-C, TC 
↓ BM abdominal 
FM 
↔ FFM, FM 
↓ VO2max 
10-day SR + overfeeding (880 
kc l/d) 
OGTT 
↑ HOMA-IR, 2h-glucose, 2h-insulin 
 glucose AUC, NEFA 
↑ plasma glucose, insulin, C-peptide 
↔hepatic insulin extraction 
Not reported 
↔TG, TC, HDL-
c, LDL-c, oxidized 
LDL 
↑ BM, FM 
↔ FFM ↓ VO2max 
Walhin et al. 
2013 [26] 
26 healthy men 
Vigorous-intensity EX 
> 30 min/ 3 day/week 
25 (7) years 
BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day treadmill running at 
70% VO2max 
OGTT 
↔Matsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
BMI, %total FM, lean mass
↓MPS
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4-week washout 
10-day SR + higher protein diet 
(400 kcal/day deficit) 
OGTT 
↔ Postprandial glucose, insulin, NEFA, 
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hepatic insulin extraction, plasma 
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Walhin et al. 
2013 [26] 
26 healthy men 
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BMI 23.8 (2.5) 
1-week SR: 12,562 (3520) to 3762 
(860) + overfeeding (+50% kcal) + 
45 min/day t admill running at 
70% VO2max 
OGTT 
↔ atsuda, B- cell function, insulin 
AUC 
↔ ALT, CRP, IL-6, 
WBC 
↔ HDL-C. LDL-
C, NEFAs, TG, 
CT 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
 
Not 
reported 
1-week SR: 10,544 (2756) to 3690 
(400) + overfeeding (+50% kcal) + 
not training 
↓ Matsuda, B- cell function  
↑ insulin AUC OGTT 
↔ ALT, CRP, IL-6 
↑ adiponectin, WBC 
↑ CT 
↔ HDL-C. LDL-
C, NEFAs, TG 
↑ BM, waist/hip 
circumference, lean 
mass 
↔ FM 
Not 
reported 
isometric MVC
Not reported
Area under curve (AUC), alanine transaminase (ALT), body mass (BM), body mass index (BMI), cardi res iratory fit ess (CRF), conti uous lu o onitoring (C M), -reac ive protein
(CRP), exercise (EX), fat mass (FM), females (F), first-degre relatives with type 2 diabetes (FDR+v ), first-degree relativ s without type di betes (FDR−ve), free fatty ds (FFA), glucose
infusion rate (GIR), high density lipoprotein cholesterol (HDL-c), homeostatic model assessm t for insulin resista ce (H A-IR), hyperinsulin mic-euglycemic duri g clamp (H-E),
LDL-C (low-density lipoprotein cholesterol), males (M), maximal voluntary contraction (MVC), muscl p otei synth sis (MPS), no -esterifi d fatty c ds (NEFA), oral glucose tolerance
test (OGTT), physical activity (PA), short physical performance battery (SPPB), soluble interc llular adhesion molecule (sICAM), step re ucti n (SR), triglycerides (TG), al cholesterol
(TC), tumor necrosis factor alpha (TNF-α), white blood cells (WBC),
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Collectively, the above data indicate that a reduction in daily physical activity of three days,
two weeks or three weeks impairs glycemic control. In addition, two weeks of step reduction increased
FM and reduced lean mass, and also had a negative impact on VO2max.
3.2. Metabolic Consequences of Acute Physical Inactivity in Overweight Adults
In the previous articles, interventions were conducted on subjects within the normal weight range.
Additionally, similar step reduction interventions have been tested on both overweight and normal
weight populations to compare the consequences of acute physical inactivity (Table 1).
To examine whether reduced physical activity in adults with central overweight could lead
to a rapid decline in metabolic and inflammatory homeostasis compared to what happens in lean
counterparts, Dixon et al. [25] performed a study in which individuals were subjected to a week of step
reduction to below 4000 steps/day. The participants of this study were nine active men with central
overweight (49 (1.0) years; BMI 29.3 (1.2) kg/m2) and nine active lean men (51.5 (1.4) years; BMI 29.3
(1.2) kg/m2) who maintained their normal diet. In the former group, subjects had significantly higher
total FM and abdominal FM levels before the intervention (these variables were not nevertheless
determined after the intervention). Results indicated that, while insulin and glucose AUC responses to
an OGTT and fasting TG concentrations increased in both groups, in the overweight group, glucose
and insulin AUC, TG and C-reactive protein (CRP) and alanine transaminase were all higher before the
intervention and remained so throughout. No changes were produced in total cholesterol, low-density
lipoprotein (LDL) or high-density lipoprotein (HDL) cholesterol over the intervention period and
neither did differences emerge between groups.
In another study, the metabolic consequences of a drop in physical activity from a daily step-count
of <10,000 to 1500 for 14 days were examined in 45 active healthy participants who continued with their
usual diet [24]. Of these 45 participants, 16 had first-degree relatives with type 2 diabetes (10 females,
6 males; 40 (14) years; BMI 27 (5) kg/m2) and 29 did not (18 females, 11 males; 33 (13) years; BMI 24 (3)).
Those in the former group had a significantly higher BMI classified as “overweight” and greater waist
and hip circumferences, although there were no significant differences in FM. Both groups experienced
a significant reduction in insulin sensitivity accompanied by a significant decrease in glucose and
insulin AUC. Although both groups showed a reduction in muscle insulin sensitivity, the overweight
group displayed a lower sensitivity. The period of reduced physical activity significantly lowered
VO2max across the study population without differences between groups. Total lean mass and lower
limb lean mass decreased significantly and there was a significant increase in total FM and liver
fat; those with overweight accumulated more android fat (1.5%) after step reduction. Lipid profiles
were also modified in that higher total cholesterol, LDL-cholesterol and TG were recorded after step
reduction, a greater TG increase being detected in the overweight subjects. All variables returned
to baseline values 14 days after the subjects resumed their usual physical activity. After resuming
normal activity, the overweight group engaged in lower amounts of vigorous activity and had lower
insulin sensitivity.
According to the findings of a study by Bowden et al. [29], obese individuals with metabolic
syndrome had lower CRF (measured as VO2max peak) than both non-obese subjects without metabolic
syndrome and non-obese individuals with metabolic syndrome, the latter being the most sedentary
population. The authors also found that higher VO2max peak, lesser sedentary time and average daily
METS were correlated with lower liver fat. Results suggested that high levels of CRF in the overweight
and obese population significantly reduced or eliminated the elevated risk of CVD and all-cause
mortality. This indicates that CRF changes the relationship between body fat and its prognosis. We
should underscore that many of the benefits of improved CRF are derived from an increase in physical
activity [30].
In conclusion, in these studies a reduction in acute physical activity negatively influenced glycaemia
control and lipid profile (TG, total cholesterol, LDL-cholesterol). Regarding body composition, step
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reduction increased FM, liver fat mass and reduced lean mass in both overweight and normal weight
subjects. However, in those overweight, consequences were usually somewhat greater.
3.3. Detrimental Health Effects of an Acute Sedentary Lifestyle in the Elderly
The prevalence of sarcopenia is high among the elderly. A loss of skeletal muscle mass and
strength has several repercussions on health, and all conditions in which muscle activity is reduced
can lead to sarcopenia [31]. Moreover, ageing is associated with abdominal obesity, an important
contributor to insulin resistance and metabolic syndrome, along with a higher level of proinflammatory
cytokines [32]. Accordingly, drastic decreases in physical activity could have worse consequences in
elderly subjects by accelerating the ageing process and the appearance of age-related diseases. As an
example, the two studies described below examine the impacts of a step reduction intervention in
elderly subjects on glycemic control, body composition, inflammatory parameters and CRF (Table 1).
Breen et al. (2013) conducted a study in healthy older adults (5 males, 5 females; 72.3 (1.0) years;
BMI 29.0 (1.8)) who were moderately active (>3500 steps/day). During the intervention, participants
reduced their daily step-count by approximately 76% of habitual levels while maintaining their dietary
habits. After this period, insulin resistance was increased and postprandial insulin sensitivity was
reduced. Fasting insulin concentrations and its peak plasma concentrations at 30 min of OGTT
were greater after step reduction and AUC for plasma glucose and insulin during OGTT increased.
The body composition data revealed that after step reduction, body fat percentage increased and
skeletal leg muscle mass was significantly reduced. Further findings were postprandial rates of
myofibrillar protein synthesis reduced by approximately 26% after the intervention with no difference
in postabsorptive rates.
A similar step-reduction intervention was conducted in 22 moderately active older adults (12 males:
69 (3) years, BMI 27.3 (4.6): 10 females; 70 (5) years, BMI 27.7 (5.1)) [28]. Participants reduced their daily
step-count by 70% and maintained their usual dietary habits. Body composition variables remained
unchanged. However, the authors reported that just a week of step reduction led to increased insulin
resistance and reduced insulin sensitivity. Moreover, glucose and insulin AUC were elevated as were
fasting plasma glucose and insulin concentration during OGTT. Also observed was a reduction in
muscle protein synthesis. What it is interesting to point out is that after the step reduction protocol,
participants were reassessed after 14 days of return to their habitual step-count. In this examination
it was confirmed, however, that glycemic control and inflammatory markers had not recovered.
In contrast, in a younger study population (36 (14) years) changes in metabolic variables produced
were reversed when normal physical activity levels were recovered [28].
In both studies conducted in older subjects, plasma concentrations of inflammatory markers
(TNF-α and CRP) were significantly increased after the step reduction intervention [27,28]. In the
second study [28], IL-6 was also increased and after returning to normal activity, inflammatory markers
were still elevated. In contrast, in the studies conducted in young individuals, no changes were
produced in inflammatory parameters [20,22,25,26].
In summary, acute physical inactivity led to impaired glycemic control, increased inflammation
and reduced muscle protein synthesis. Inactivity may also reduce fat free mass while increasing
FM. In addition, recovering normal levels of activity in the elderly could be harder compared to
younger subjects.
3.4. Metabolic Effects of Acute Physical Inactivity plus Overfeeding
Energy balance is the state in which energy intake equals energy expenditure. A positive energy
balance, whereby energy intake exceeds expenditure, can lead to weight gain due to increased body
fat [33]. In the studies described in the previous section, participants kept up their usual dietary intake
while reducing energy expenditure, resulting in a positive energy balance that may have contributed
to the observed metabolic changes [19,20,24,25]. In this section, we review the impact of physical
inactivity when added to a diet intervention (Table 1).
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In a study of the effects of two weeks of step reduction combined with overfeeding, nine healthy
young men (24.3 (3.3) years; BMI 21.6 (2.5) kg/m2) undertook 14 days of step reduction from 10,278 (2399)
to 1521 (488) steps/day and increased their daily total energy intake by 50% kcal [22]. This study showed
that insulin sensitivity reduction occurs after three days of inactivity and overfeeding. Clamp-derived
insulin sensitivity was reduced after 14 days of inactivity and oral glucose tolerance remained unaffected.
The insulin response to OGTT increased after the first and the second week. Body composition was
affected by the intervention, in that body weight was higher due to an increase in total FM (1.5 (0.5) kg;
p < 0.05), and in android, gynoid and visceral fat. Finally, plasma levels of leptin and adiponectin
increased after the intervention and no changes in TG or FFA were observed. The authors of this study
also reported that after 16 days of returning to an uncontrolled free-living environment, body weight
and adiposity were still elevated while remaining variables returned to baseline values.
Interestingly, one study explored whether metabolic dysfunction caused by inactivity might be
blunted by energy restriction [23]. Ten physically active men and women (24 (1) years) reduced their
daily steps from 10,000 to 5000 for 10 days. Participants completed two periods of physical inactivity
while consuming either a control diet (16% kcal from protein, 64% kcal from carbohydrate, 20% kcal
from fat) or a higher-protein diet (30% kcal from protein, 50% kcal from carbohydrate, and 20% kcal
from fat) in a randomized crossover design. In both diets, energy intake was decreased by 15–20% of
total energy expenditure to offset the reduction in energy expenditure (400 kcal/day). As a positive
control condition, a group of subjects from the initial sample (n = 5) repeated the same protocol of
inactivity in association with overfeeding (35% kcal). The results of this study revealed that when
diet was controlled, body fat was not altered by physical inactivity and body weight was significantly
reduced; abdominal FM was also lowered. In contrast, when overfeeding was accompanied by
inactivity, both body weight and body fat went up. Further, when overfeeding was combined with
inactivity, the authors observed increases in fasting blood glucose, plasma insulin, plasma c-peptide,
insulin resistance, and 2 h postprandial glucose and insulin concentrations. However, when the diet
was controlled none of these changes were produced.
Other authors have looked at what happens when a reduction in physical activity and overfeeding
are accompanied by an exercise intervention [26]. Over one week, 26 physically active men (25 (7) years;
BMI 23.8 (2.5)) were randomly assigned to two groups. In both groups, physical activity was restricted
to under 4000 steps/day and energy intake increased (50% kcal) while individuals in one of the groups
undertook 45 min of daily treadmill running at 70% of VO2max. In both groups, increases were recorded
in body weight, waist/hip circumference and lean mass. In the group of subjects who did not train,
insulin sensitivity and B-cell function were reduced and the insulin response to OGTT was increased.
This group also showed an increase in total cholesterol and adiponectin. However, the addition of
physical exercise was able to abolish these changes.
Taken together, these findings indicate that energy balance plays a key role in the metabolic
consequences of acute physical inactivity. Accordingly, while overeating could worsen its repercussions,
energy restriction could help avoid its impacts. Although physical exercise seems to improve glycemic
control, a positive energy balance still affects body composition. In the studies reported, however,
calorie intake was controlled, so it is unknown whether reduced physical activity may have led to
reduced energy intake.
Physical activity plays an important role in energy balance, and subjects engaging in higher levels
of physical activity may have improved sensitivity of the appetite control system [34]. Evidence shows
that there is weak coupling between energy intake and expenditure in individuals displaying low
levels of daily physical activity, but strong coupling with high levels of physical activity [35].
In 1956, Mayer [36] described that calorie intake increases with activity only within a certain zone
of “normal activity”. This author also confirmed that below a level of physical activity or so-called
“sedentary zone”, a further decrease in activity is not followed by a decrease in food intake. Recent
investigations have also shown that a reduction in physical activity is not usually offset by a reduction
in energy intake, resulting in a positive energy balance [37,38]. Further, it has been proposed that
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sedentary activities not only reduce energy expenditure, but they also promote increased food intake.
Hence activities such as watching television or cognitive tasks stimulate food intake such that the
sensations of satiety and fullness are ignored leading to overconsumption [39]. This evidence suggests
it is highly likely that a significant reduction in physical activity will not be accompanied by a reduction
in energy intake and this will result in a positive energy balance likely worsening the metabolic effects
of sedentary behavior.
3.5. Manipulating Dietary Intake to Offset the Metabolic Impacts of Confinement
While it is important to remain active to avoid the problems an acute sedentary lifestyle brings,
what about our attitude to food during this period of confinement? On the one hand, there may be
overfeeding, while on the other, calorie intake may be restricted due to reduced activity or physical
inactivity. Restricted calorie intake could be an optimal option for our current situation. This means a
diet lower in a given percentage of calories than our regular diet, but that, nevertheless, is balanced to
include all the necessary nutrients. Research in some animals has shown that the intake of up to 40%
fewer calories has an impressive positive effect on markers of disease and ageing [18]. In humans,
a few randomized controlled clinical trials have examined the effects of calorie restriction on health.
The findings of a study performed in healthy subjects who underwent a three-month period of calorie
restriction, i.e., five consecutive days per week of a fasting-mimicking diet low in calories, proteins, and
sugars but high in unsaturated fatty acids, were reduced BMI, trunk, and total body fat [40]. Likewise,
reductions were recorded in blood pressure, triglycerides, total and low-density lipoprotein cholesterol,
C-reactive protein, and insulin-like growth factor 1 (IGF-1). The authors concluded that cycles of a
five-day fasting-mimicking diet were safe, feasible, and effective in reducing risk factors associated
with metabolic-related diseases.
In a two-year follow-up clinical trial, the effect of two years of 15% calorie restriction was assessed
in healthy individuals. Results indicated an average weight loss of 8.7 kg (70% was body fat) in the
calorie restriction group versus an average gain of 1.8 kg in the control group. Further, subjects in
the restricted calorie intake group showed a 10% reduction in the metabolic rate of sleep, associated
with reduced levels of reactive oxygen species and thyroid activity (reduced T3 and T4), which are
biomarkers of aging [41]. In another study carried out in eighteen healthy and physically active
subjects, the effects of caloric restriction close to 40% of the standard calorie intake for six weeks were
assessed [42]. Diet was based on three days of severe restriction (600–800 Kcal) per week and normal
intake for the rest of the week. Results indicated considerable weight loss including reduced fat mass
(mostly android) and a less appreciable effect on fat-free mass. Hence, the option of calorie restriction
should be considered with caution due to the lack of evidence in humans.
The key during this period of confinement would be a balanced diet comprising all the necessary
nutrients, including healthy fats with balanced levels of sugar and cholesterol. During confinement,
low-calorie diets should not be recommended, as they are not effective in the long term, and do not
provide sufficient energy for a person in this situation of staying at home. Carbohydrates are an
appropriate source of energy and are needed daily, mainly if associated with aerobic exercise. Foods
rich in carbohydrates with a low glycemic index (whole grains, brown rice, vegetables, legumes, fruits,
etc.) and proteins are an essential part of the diet, especially during this period of greater inactivity and
we should avoid carbohydrates with a high glycemic index such as sugars, sweets, or bread. Foods
rich in proteins with a lower percentage of fat such as chicken and turkey meat, fish, cooked eggs, fresh
cheeses, legumes (soy), as well as dairy products such as yogurt and cottage cheese, are recommended
because proteins have a stimulating effect on metabolism and are involved in the elimination of fats.
Therefore, the combination of an adequately balanced diet and regular physical exercise, should serve
to maintain a stable metabolic balance.
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3.6. Physical Activity to Mitigate the Metabolic Impacts of Confinement
In many countries, an undesirable effect of the COVID-19 pandemic is restricted outdoor physical
exercise. Recommendations include indoor walking every 2 h in order to stimulate both cardiovascular
and musculoskeletal systems. Aerobic exercise, such as jogging at home if there is enough space, is
highly recommended, as well as performing flexo-joint extension (shoulders, elbows, wrists, back,
hip, knees, and ankles) and strength, flexibility and stretching exercises of the main muscle groups.
A central-question is: what type of training is appropriate for an individual with metabolic syndrome?
In a meta-analysis examining the effects of aerobic exercise training, strength training, or both combined,
on cardiovascular risk factors in patients with metabolic syndrome, it was observed that aerobic
training improved waist circumference, fasting blood glucose, HDL-cholesterol, triglycerides, diastolic
blood pressure, and VO2peak [43]. No changes were related to strength training alone, probably due
to the limited data available. Accordingly, high-intensity aerobic training performed over more than
12 weeks (3 days/week), shows the most marked effects on cardiovascular risk factors [43]. Inactivity
slows the metabolic benefits of exercise, while exercise improves postprandial lipemia levels, glucose
tolerance, and insulin sensitivity, all of which are risk factors for CVD. Another study highlights that
physical inactivity (e.g., sitting 13.5 h/day and walking fewer than 4000 steps a day) provokes resistance
to metabolic improvements that usually result from an acute episode of aerobic exercise, emphasizing
that exercise, a heart-healthy diet, and an active lifestyle should be combined to achieve a healthy
cardiometabolic profile [44].
Another added problem during this period of home confinement at is that the only form of
exercise for many people is walking up and down the corridor of their house. Thus, the question
arising is how many steps per day are recommended? Taking more steps per day (8000 vs. 4000 steps
per day) is associated with lower all-cause mortality but a significant association has not been found
between step intensity and mortality after adjusting for the total number of steps per day [45]. It is
essential to walk as much as possible regardless of intensity, since muscle is an endocrine organ that
modulates the production of substances according to their activity, requiring minimal muscle activation
to obtain benefits [13]. During confinement, it is very likely that physical activity drops drastically
possibly resulting in more hours of bed rest, with the consequent loss of muscle mass and its impaired
function, and increases in glucose intolerance. Nutrition will play an even more significant role at this
challenging moment and must include a consumption in the range of 1.4–2.0 g/kg per day protein
to protect from the consequences of muscle inactivity [46,47]. Protein intake should be customized
according to different factors, such as the type of population (young or older) [48], energy status,
the quality of protein intake or the mode and intensity of exercise [46].
An exercise program for the confinement period has been proposed [49]. Recommendations
include increasing the frequency of exercise to 5–7 days per week, 200–400 min of aerobic training
and 2–3 days of resistance training. Mobility should be included every day as well as balance and
coordination distributed through different training. This should be done at least two times per week.
For older people, moderate intensity exercise is recommended during quarantine. Exercise may be
performed without any specific training materials. Resistance training can be done through body
weight exercises, such as squats, push-ups or sit-ups. Household items such as water bottles or packets
of food can be used as weights. Different examples of aerobic exercise are dancing, stair climbs and
walking or running on the spot. Balance exercises could be performed via stepping over obstacles or
walking along a straight line marked out on the floor [49,50]. Additionally, yoga or traditional Tai Ji
Quan can be considered as they do not require any equipment or large space [50].
Resistance training has been demonstrated to reduce the loss of muscle mass and muscle
strength [51–53] and improve bone density [54], metabolic health and insulin resistance [53]. Resistance
training should be properly designed for older adults following principles of individualization,
periodization, and progression [53]. However, minimally supervised home-based training has also
been shown to be a safe and effective method of increasing body muscle strength [51]. Resistance
training can be useful to fight against the metabolic and physical consequences of COVID-19. However,
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exercise programs should consider other important components: aerobic, balance, coordination and
mobility [49].
4. Limitations
As the main limitation of the studies reviewed, with the exception of three studies [24,26,28] (n = 45,
n = 26, n = 22, respectively), most had <20 participants, so statistical power was low. Participants were
mainly males (n = 119) and there was a lower number of females (n = 51). Additionally, none of the
studies reported on sex differences, an aspect that would be interesting to explore. Nevertheless, as
results exist for both sexes, we believe that recommendations can be followed by both.
Another aspect we should highlight is the fact that not all the articles measured the same variables.
Although all examined glycemic control, not all analyzed CRF, body composition, lipid profile or
inflammatory factors. These variables could have provided much evidence of the deleterious impact of
step reduction. We found no study including a short term step reduction intervention in obese persons
or people with metabolic syndrome. According to the high prevalence of both syndromes and their
pathogens, it is probably that in these populations, the health impacts of short term physical inactivity
will be worse.
In most of the studies reviewed, while physical activity was reduced, participants maintained
their dietary habits and, as a result, their energy balance was positive [19,20,24,25,27,28]. Another three
articles added overfeeding to the intervention [22,23,26], and just one examined calorie restriction [23].
In these studies, most deleterious consequences were avoided. So it is unknown if the negative
repercussions of acute physical inactivity are derived from the inactivity itself, the positive energy
balance or from both aspects. According to the current evidence, home exercise as well as a healthy
balanced diet avoiding overeating could be a good strategy to mitigate the impacts of acute physical
inactivity. Further research on this topic is needed.
5. Conclusions
Metabolic syndrome, also known as “insulin resistance syndrome”, is defined as “a constellation
of interconnected physiological, biochemical, clinical, and metabolic factors that directly increases
the risk of atherosclerotic CVD, type 2 diabetes mellitus, and all-cause mortality” [55]. Metabolic
syndrome is strongly linked to insulin resistance, oxidative stress, inflammation, obesity, endothelial
dysfunction and CVD [56]. In turn, physical inactivity has been related to every described risk factor for
metabolic syndrome: dyslipidemia, hypertension, hyperglycemia, visceral obesity, and prothrombotic
and proinflammatory events (Figure 2).
Insulin resistance is a central component of metabolic syndrome [56] and while high levels of
daily physical activity can prevent insulin resistance, physical inactivity is a primary cause of insulin
resistance and a loss of insulin sensitivity in skeletal muscle [2]. In the studies reviewed, it was observed
that just two weeks of physical inactivity and a positive energy balance can increase insulin resistance
and modify glycemic control [19–28]. Obesity and visceral obesity are also central components of
metabolic syndrome [55,56] with an important role in CVD [57] through different mechanisms such as
insulin resistance and the induction of a proinflammatory state [58]. The studies reviewed detected
increases in body fat [22–24,27] and abdominal fat mass [19,22,24] after just one or two weeks of step
reduction associated with a positive energy balance.
The role of inflammation in the pathogenesis of metabolic syndrome and CVD has been well
documented [55,56,59]. In the studies conducted in elderly subjects reviewed here, it was confirmed
that two weeks of physical inactivity led to increases in TNF-α, IL6 and CRP [27,28]. TNF-α and
IL-6 are cytokines with endocrine, autocrine and paracrine functions, and their gene expression is
increased in the adipocytes, macrophages and lymphocytes of obese individuals [56]. TNF-α acts
locally on adipocytes and reduces insulin sensitivity via different mechanisms, increases FFA levels
through the induction of lipolysis, and inhibits adiponectin release [60]. This cytokine also attenuates
nitric oxide-mediated vasodilation and is involved in the vascular pathology of metabolic syndrome,
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atherosclerosis and coronary disease [56]. IL-6 creates insulin resistance in the liver and enhances the
hepatic synthesis of acute phase proteins such as CRP and fibrinogen. CRP shows high correlation
with metabolic syndrome, diabetes and CDV, and fibrinogen leads to a prothrombotic state [56,60].
IL-6 also promotes the expression of adhesion molecules by endothelial cells and activates the local
renin-angiotensin system, whose activation contributes to metabolic syndrome development [56,60].
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Acute sedentarism can be deleterious for health though other mechanisms. It has been reported
that short term physical inactivity lowers VO2max [20,22–24] and also reduces lean mass and fat free
mass, with greater impacts on the lower body [19,20,24,27]. Both low skeletal muscle mass and maximal
aerobic capacity (VO2max) are biomarkers associated with a shorter life expectancy [2]. The impact of
this reduction in muscle mass could be especially important in the elderly, due to a higher prevalence
of sarcopenia and its health impacts in these subjects. Moreover, sarcopenia combined with obesity
(sarcopenic obesity) has been linked to a worse metabolic impact and increased risk of mortality [61].
More research is needed to examine whether energy restriction could avoid the consequences
of acute physical inactivity as suggested in one of the articles reviewed [23]. Nevertheless, there is
evidence to support that at lower levels of physical activity, energy intake is dysregulated leading to a
positive energy balance [35–38]. Maintaining food glycemic control is a specific measure in patients
with diabetes to help reduce infection risk and severity. In effect, it has been also recommended that
attention be paid to nutrition and adequate protein intake, along with exercise to improve immunity [62].
Short-term physical inactivity and a positive energy balance can have several consequences for health
related to reduced insulin sensitivity, higher total body and central fat, and a proinflammatory state,
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which are all central risk factors for metabolic syndrome. For the elderly, consequences could be worse,
increasing the risk of developing sarcopenic obesity.
According to recent evidence, adequate control of metabolic disorders is important to reduce the
risk of severe COVID-19. We should try to avoid the deleterious consequences of physical inactivity and
positive energy balance by maintaining physical activity and exercise levels in a safe home environment
and adhering to a healthy diet. Of course, this is also important for people without metabolic disorders
to avoid the reported deleterious effect of physical inactivity and positive energy balance, which may
prompt the development of metabolic syndrome and its comorbidities. COVID-19 varies from a mild
self-limiting flu-like illness to full-blown pneumonia, respiratory failure and death [62]. Hypertension,
diabetes, and CVD have been identified as potential risk factors for the more severely ill patients.
In addition, COVID-19 could also enhance damage to the heart in patients with CVD [63,64]. As obesity
increases, so does risk of chronic disease related to metabolic syndrome and based on recent data,
obese individuals are also being considered at high risk for severe complications of COVID-19 [65,66].
Accordingly, our recommendations during this period of confinement are to avoid overeating by
following a healthy balanced diet. This diet should be based on carbohydrates with a low glycemic
index, such as vegetables, legumes or fruits, healthy fats and food rich in proteins with a lower
percentage of fat. Moreover, calorie intake may be restricted due to reduced activity or physical
inactivity. This nutrition recommendation should be combined with an adequate daily physical
activity program designed by sports science specialists to prevent metabolic-related health problems.
This program should consider different components: resistance, aerobic, mobility, coordination and
balance. The recommended frequency of training is 5–7 days per week, including at least 2–3 days of
resistance training.
Once COVID-19 transmission is controlled, different countries are setting new regulations in
which exercising in the street is allowed. Each set of regulation may have different rules, in terms of
time, or number of people training together. Depending on the country, personal training or in small
groups might be permitted. However, reopening of gym or sport centers to the population at large
could take longer. For this reason, resistance training should continue at home as recommended here,
as well as exercise for mobility, coordination and balance. As indicated by the studies reviewed in this
article, short term physical inactivity can lead to a reduction in CFR and also in muscle mass. In some
countries this inactivity has been much longer. Accordingly, people must consider that their fitness level
is lower than before confinement if they begin to exercise in the street, such as running. Counselling
by a sports science specialists could be useful to avoid injuries. Likewise, it is imperative that all the
actions we carry out comply with the social distancing recommended by the health authorities.
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